SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-118057
Filing Date
2016-08-10
Accepted
2016-08-10 16:46:29
Documents
61
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q v446124_10q.htm 10-Q 397535
2 EXHIBIT 31.1 v446124_ex31-1.htm EX-31.1 7642
3 EXHIBIT 31.2 v446124_ex31-2.htm EX-31.2 7648
4 EXHIBIT 32.1 v446124_ex32-1.htm EX-32.1 4139
5 EXHIBIT 32.2 v446124_ex32-2.htm EX-32.2 4163
  Complete submission text file 0001144204-16-118057.txt   3702987

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT eyeg-20160630.xml EX-101.INS 647488
7 XBRL TAXONOMY EXTENSION SCHEMA eyeg-20160630.xsd EX-101.SCH 38284
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eyeg-20160630_cal.xml EX-101.CAL 44007
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eyeg-20160630_def.xml EX-101.DEF 270365
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE eyeg-20160630_lab.xml EX-101.LAB 333276
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eyeg-20160630_pre.xml EX-101.PRE 314609
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36672 | Film No.: 161822019
SIC: 2834 Pharmaceutical Preparations